ADX-2191 (intravitreal methotrexate 0.8%)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative VitreoretinopathyNCT04136366ALDXPhase 3Completed2022-06-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.